Loading…
Based on limited metadata with no full letter text available, Young Health Products received an FDA Warning Letter on January 24, 2018, regarding product(s) classified outside the standard medical device or drug categories. Without access to the specific subject line and violation details, the exact nature of the regulatory concerns cannot be determined from this metadata alone. The issuing office is also not specified in the available information. To understand the full scope of violations and regulatory requirements, the complete Warning Letter would be needed.